Proximity map for p53 unveils a strong link with PML Nuclear Bodies in HEK293 cells
Edith De BruyckeriD, Giel VandemoorteleiD, Delphine De SutteriD, George D. MoschonasiD, Sven EyckermaniD
Abstract
The tumor suppressor p53 is among the most studied proteins in cancer, with mutations in nearly half of all tumors. Even when TP53 is intact, its regulatory pathways are often disrupted, underscoring its central role in tumorigenesis. To explore how cellular context shapes the subcellular environment of p53, we used BioID proximity labeling in HEK293 cells. These experiments revealed a striking enrichment of proteins involved in SUMOylation and proteins that reside in PML nuclear bodies. A strong enrichment of the adenoviral E1B protein, originally used for transformation of this cell line, may explain this striking observation, and can shed light on the remarkable difference with the proximity map of p53 in the HCT116 colon carcinoma cell line. Strong enrichment of the mediator complex in HCT116, related to active p53-dependent transcription, is missing in 293 cells and can explain the lack of p53 transcriptional activity in these cells. This study emphasizes how cellular transformation can affect the proximal proteome of a key protein in cell cycle control, DNA repair, apoptosis, senescence and metabolism, and confirms previously reported inhibition of p53-dependent transcription by sequestering the protein in PML nuclear bodies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The E2F4/p130 repressor complex cooperates with oncogenic ΔNp73α to promote cell survival in human papillomavirus 38 E6/E7-transformed keratinocytes and in cancer cells
V. Taverniti, H. Krynska, … K. Zanier·bioRxiv·Oct 27, 2022
- p53 binding sites in normal and cancer cells are characterized by distinct chromatin context
Feifei Bao, Peter R. LoVerso, … Feng Cui·Cell CyclePeer-reviewed·Aug 18, 2017
- Pre-existing levels of pro-survival proteins and induction of BCL-XL dictate cell fate after p53 activation
Allan Shuai Huang, Elizabeth Lieschke, … Andreas Strasser·bioRxiv·Jul 2, 2026
- Suppression of HSF1 activity by wildtype p53 creates the driving force for p53 loss-of-heterozygosity, enabling mutant p53 stabilization and invasion
O. C. Sener, A. Stender, … R. Schulz-Heddergott·bioRxiv·Apr 23, 2020
- Cell type-dependent control of p53 transcription and enhancer activity by p63
Gizem Karsli Uzunbas, Faraz Ahmed, Morgan A. Sammons·Journal of Biological ChemistryPeer-reviewed·May 21, 2019
- Human Adenovirus (HAdV) mediated inhibition of the tumor suppressor p53 is controlled by SUMOylation of the viral E2A/DBP protein
Miona Stubbe, Hans Christian Stubbe, … Sabrina Schreiner·bioRxiv·Feb 7, 2025